5-methyl-2-phenyl-isoxazolidine-3-one and the erythropoietic system. A contribution to the attempts to predict side effects on the basis of subchronic toxicity tests.
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004285:Dogs; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006651:Histocytochemistry; D008297:Male; D051381:Rats; D012156:Reticulocytes / Q000187:drug effects; D013045:Species Specificity; D013154:Spleen / Q000033:anatomy & histology / Q000187:drug effects
D006454:Hemoglobins